A phase III randomized clinical trial comparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with early-stage cervical cancer
- PMID: 38992720
- PMCID: PMC11238402
- DOI: 10.1186/s13063-024-08318-z
A phase III randomized clinical trial comparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with early-stage cervical cancer
Abstract
Background: Cervical cancer is the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death in women, The standard treatment recommendation for women with early cervical cancer is radical hysterectomy with pelvic lymph node dissection, however, articles published in recent years have concluded that the treatment outcome of laparoscopic surgery for cervical cancer is inferior to that of open surgery. Thus, we choose a surgically new approach; the laparoscopic cervical cancer surgery in the open state is compared with the traditional open cervical cancer surgery, and we hope that patients can still have a good tumor outcome and survival outcome. This trial will investigate the effectiveness of laparoscopic cervical cancer surgery in the open-state treatment of early-stage cervical cancer.
Method and design: This will be an open-label, 2-armed, randomized, phase-III single-center trial of comparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with early-stage cervical cancer. A total of 740 participants will be randomly assigned into 2 treatment arms in a 1:1 ratio. Clinical, laboratory, ultrasound, and radiology data will be collected at baseline, and then at the study assessments and procedures performed at baseline and 1 week, 6 weeks, and 3 months, and follow-up visits begin at 3 months following surgery and continue every 3 months thereafter for the first 2 years and every 6 months until year 4.5. The primary aim is the rate of disease-free survival at 4.5 years. The secondary aims include treatment-related morbidity, costs and cost-effectiveness, patterns of recurrence, quality of life, pelvic floor function, and overall survival.
Conclusions: This prospective trial aims to show the equivalence of the laparoscopic cervical cancer surgery in the open state versus the transabdominal radical hysterectomy approach for patients with early-stage cervical cancer following a 2-phase protocol.
Trial registration: ChiCTR2300075118. Registered on August 25, 2023.
Keywords: Based on open state; Cervical cancer; Laparoscopic surgery; Phase III clinical trial; Radical hysterectomy.
© 2024. The Author(s).
Conflict of interest statement
The authors and all members of the trial indicate they have no competing interests.
Similar articles
-
Robot-assisted approach to cervical cancer (RACC): an international multi-center, open-label randomized controlled trial.Int J Gynecol Cancer. 2019 Jul;29(6):1072-1076. doi: 10.1136/ijgc-2019-000558. Epub 2019 Jun 14. Int J Gynecol Cancer. 2019. PMID: 31203203 Clinical Trial.
-
A multicenter non-inferior randomized controlled study comparing the efficacy of laparoscopic versus abdominal radical hysterectomy for cervical cancer (stages IB1, IB2, and IIA1): study protocol of the LAUNCH 2 trial.Trials. 2022 Apr 8;23(1):269. doi: 10.1186/s13063-022-06245-5. Trials. 2022. PMID: 35395868 Free PMC article.
-
A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer.J Minim Invasive Gynecol. 2008 Sep-Oct;15(5):584-8. doi: 10.1016/j.jmig.2008.06.013. J Minim Invasive Gynecol. 2008. PMID: 18722970 Clinical Trial.
-
Radical Hysterectomy for Cervical Cancer: the Right Surgical Approach.Curr Treat Options Oncol. 2022 Jan;23(1):1-14. doi: 10.1007/s11864-021-00919-z. Epub 2022 Feb 15. Curr Treat Options Oncol. 2022. PMID: 35167007 Review.
-
The value of laparoscopic surgery to stage gynecological cancers: present and future.Minerva Ginecol. 2009 Aug;61(4):319-37. Minerva Ginecol. 2009. PMID: 19745797 Review.
References
-
- Koh WJ, Abu-Rustum NR, Bean S, et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(1):64–84. - PubMed